INDV SCHEDULE 13G: SEC filing
Millennium Management LLC and affiliated entities
Filed with the SEC on · accession 0001104659-26-112446
INDV filed a SCHEDULE 13G (schedule 13g) with the SEC on Sep 30, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -2.0% by the first close after the filing.
Summary of the filing
Millennium Management LLC and affiliated entities filed a Schedule 13G disclosing beneficial ownership of Indivior Pharmaceuticals common stock, accompanied by a joint filing agreement.
Key details
How INDV stock reacted
Close before
$36.59
Sep 29, 2026
First close after
-2.02%
$35.85
5 trading days
-1.89%
$35.90
Since filing
-0.85%
$36.28
✦ Ask GOAX AI about this filing — what it means for INDV, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for INDV?
Click hereFrequently asked questions
What did INDV file with the SEC on Sep 30, 2026?
INDV filed a SCHEDULE 13G (SEC filing). Millennium Management LLC and affiliated entities filed a Schedule 13G disclosing beneficial ownership of Indivior Pharmaceuticals common stock, accompanied by a joint filing agreement.
How do I read a SCHEDULE 13G?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).
How did INDV stock react to this filing?
INDV closed at $36.59 before the filing and $35.85 on Sep 30, 2026 (-2.02%). Five trading days later: $35.90 (-1.89%).
Other INDV SEC filings
Get alerts when INDV files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days